biomarkers

heart over ekg

Biotech

Ventyx's CV drug rapidly reduces cardio risk biomarker

Ventyx Biosciences’ cardiovascular disease drug cut levels of a biomarker for stroke and other serious risks by almost 80% within a week.

James Waldron Oct 23, 2025 9:45am

Alzheimers PET scans

Lilly calls for improvements to Alzheimer's testing in Europe

Oct 7, 2025 9:30am

movie clapper film premiere production

Etiome emerges with $50M from Flagship, plans to preempt disease

Apr 24, 2025 6:00am

Donated human blood conservation in a hospital

Grifols garners $21M to hunt for early Parkinson's biomarkers

Jan 14, 2025 6:00am

Cells

Bruker spools up spatial biology division from acquired assets

Oct 11, 2024 12:00pm

AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC

Sep 8, 2024 12:22pm